What is the Place of Fluoroquinolones in the Treatment of Community-Acquired Respiratory Tract Infections?
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 57 (6) , 851-853
- https://doi.org/10.2165/00003495-199957060-00002
Abstract
The newest (third generation) fluoroquinolones are potentially useful agents in the management of community-acquired respiratory tract infections. This is mainly due to their increased activity...Keywords
This publication has 8 references indexed in Scilit:
- Community‐Acquired Pneumonia in Adults: Guidelines for ManagementClinical Infectious Diseases, 1998
- How Do We Achieve Cost-effective Options in Lower Respiratory Tract Infection Therapy?Chest, 1998
- Pharmacodynamics of LevofloxacinJAMA, 1998
- Long-Term Persistence of Ciprofloxacin-Resistant Haemophilus influenzae in Patients with Cystic FibrosisThe Journal of Infectious Diseases, 1996
- Results of the Alexander Project: A continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogensDiagnostic Microbiology and Infectious Disease, 1996
- Temafloxacin Syndrome: Review of 95 CasesClinical Infectious Diseases, 1994
- Medical Section pf the American Lung Association: Guidelines for the Initial Management of Adults with Community-acquired Pneumonia: Diagnosis, Assessment of Severity, and Initial Antimicrobial TherapyAmerican Review of Respiratory Disease, 1993
- Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. The British Thoracic Society.1993